PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Closed 01-16 16:00:00 EST

4.37

-0.02

-0.46%

盘后4.37

+0.000.00%

17:16 EST

High4.59	Low4.36	Vol57.17K
Open4.45	D1 Closing4.39	Amplitude5.22%
Mkt Cap72.69M	Tradable Cap43.98M	Total Shares16.63M
T/O252.04K	T/O Rate0.57%	Tradable Shares10.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":4.37,"timestamp":1768597200000,"preClose":4.39,"halted":0,"volume":57168,"hourTrading":{"tag":"盘后","latestPrice":4.37,"preClose":4.37,"latestTime":"17:16 EST","volume":444,"amount":1940.28,"timestamp":1768601794809},"delay":0,"floatShares":10063400,"shares":16634800,"eps":-2.81,"marketStatus":"Closed","change":-0.02,"latestTime":"01-16 16:00:00 EST","open":4.45,"high":4.585,"low":4.356,"amount":252036.590184,"amplitude":0.052164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.81,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":5,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":4.39,"postHourTrading":{"tag":"盘后","latestPrice":4.37,"preClose":4.37,"latestTime":"17:16 EST","volume":444,"amount":1940.28,"timestamp":1768601794809},"volumeRatio":0.703885,"impliedVol":3.8527,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PYPD/tweets","defaultTab":"tweets","newsList":[{"id":"2600709776","title":"PolyPid Ltd. Shareholders to Vote on Compensation Terms for Board Chairman at Upcoming Extraordinary Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2600709776","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600709776?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:01","pubTimestamp":1767214913,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. has scheduled an Extraordinary General Meeting of shareholders for February 4, 2026, where shareholders will vote on a proposal to approve the compensation terms of Ms. Brooke Story, chairman of the company's board of directors. The Board of Directors recommends voting in favor of the proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDLf1KzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2591878939","title":"Press Release: PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591878939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591878939?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:30","pubTimestamp":1765891800,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, Dec. 16, 2025  -- PolyPid Ltd.  , a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025.\"Brooke's appointment marks an exciting and pivotal moment for PolyPid,\" said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. \"Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transforming our clinical success into a commercial reality.\". \"I am honored to join PolyPid at this pivotal stage in the Company's development,\" said Ms. Story. \"I look forward to supporting the team as it leverages its delivery platform to address critical, high-cost needs in surgical infection prevention, creating a clear opportunity to build significant enterpris","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","BK4007","PYPD","BK4516","BK4588","BK4006","BK4585","BK4520"],"gpt_icon":0},{"id":"2588041874","title":"BRIEF-Polypid Announces Positive FDA Pre-NDA Meeting Minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2588041874","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588041874?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:33","pubTimestamp":1764768830,"startTime":"0","endTime":"0","summary":"BRIEF-Polypid Announces Positive FDA Pre-NDA Meeting Minutes Dec 3 (Reuters) - PolyPid Ltd PYPD.O:POLYPID ANNOUNCES POSITIVE FDA PRE-NDA MEETING MINUTES FOR D-PLEX SUPPORTING NDA SUBMISSIONPOLYPID LTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2588490090","title":"PolyPid Ltd - FDA Agreed to a Rolling Nda Review, Allowing PolyPid to Submit First Completed Sections in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588490090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588490090?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:30","pubTimestamp":1764768600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2588049727","title":"PolyPid Announces Positive FDA Pre-Nda Meeting Minutes for D-Plex₁₀₀ Supporting Nda Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2588049727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588049727?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:30","pubTimestamp":1764768600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2586298185","title":"PolyPid Expands Share Offering to Strengthen Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298185","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298185?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:29","pubTimestamp":1764192585,"startTime":"0","endTime":"0","summary":"PolyPid ( ($PYPD) ) just unveiled an announcement. On November 26, 2025, PolyPid Ltd. announced an increase in the maximum aggregate offering price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-expands-share-offering-to-strengthen-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-expands-share-offering-to-strengthen-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2586458476","title":"PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586458476","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586458476?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:30","pubTimestamp":1764077400,"startTime":"0","endTime":"0","summary":"Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEXPETACH TI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194326/0/en/PolyPid-to-Participate-in-ROTH-Capital-Partners-Virtual-KOL-Event-on-December-10-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","KOL","ROTH","X","BK4588","BK4006","BK4520","BK4585","BK4516","BK4007"],"gpt_icon":0},{"id":"2583597975","title":"PolyPid Is Maintained at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2583597975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583597975?lang=en_us&edition=fundamental","pubTime":"2025-11-14 00:48","pubTimestamp":1763052480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYPD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2025 11:48 ET (16:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0},{"id":"2583561230","title":"Roth MKM Remains a Buy on PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583561230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583561230?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:37","pubTimestamp":1763033873,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM maintained a Buy rating on PolyPid, with a price target of $9.00. According to TipR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-polypid-pypd-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-polypid-pypd-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2583569707","title":"PolyPid price target lowered to $9 from $10 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2583569707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583569707?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:16","pubTimestamp":1763032563,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on PolyPid (PYPD) to $9 from $10 and keeps a Buy rating on the shares following the Q3 report. The fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polypid-price-target-lowered-to-9-from-10-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polypid-price-target-lowered-to-9-from-10-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"gpt_icon":0},{"id":"2583306355","title":"PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2583306355","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583306355?lang=en_us&edition=fundamental","pubTime":"2025-11-13 00:55","pubTimestamp":1762966526,"startTime":"0","endTime":"0","summary":"Analyst Brandon Folkes of H.C. Wainwright reiterated a Buy rating on PolyPid, retaining the price target of $13.00. Brandon Folkes has given his Bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/polypids-promising-future-buy-rating-backed-by-d-plex100-progress-and-expanding-drug-delivery-pipeline-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/polypids-promising-future-buy-rating-backed-by-d-plex100-progress-and-expanding-drug-delivery-pipeline-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","PRGS"],"gpt_icon":0},{"id":"2582376981","title":"Biopharma firm PolyPid's Q3 net loss narrows to $7.5 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376981","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376981?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:38","pubTimestamp":1762951099,"startTime":"0","endTime":"0","summary":"Biopharma firm PolyPid's Q3 net loss narrows to $7.5 mlnOverviewPolyPid reports Q3 net loss of $7.5 mln, down from $7.8 mln last yearCompany advances regulatory strategy with pre-NDA meeting scheduled","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2582973376","title":"PolyPid reports Q3 EPS (37c), consensus (52c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582973376","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582973376?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:35","pubTimestamp":1762950915,"startTime":"0","endTime":"0","summary":"“This past quarter was significant for PolyPid (PYPD) as we continue to progress toward bringing D-PLEX to market,” said Dikla Czaczkes Akselbrad, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polypid-reports-q3-eps-37c-consensus-52c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polypid-reports-q3-eps-37c-consensus-52c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"gpt_icon":0},{"id":"2582376808","title":"PolyPid Q3 Cash & Equivalents $18.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376808","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376808?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:31","pubTimestamp":1762950706,"startTime":"0","endTime":"0","summary":"PolyPid Q3 Cash & Equivalents $18.8M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799527/polypid-q3-cash-equivalents-18-8m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2582376803","title":"PolyPid Q3 EPS $(0.37) Beats $(0.44) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376803","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376803?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:30","pubTimestamp":1762950656,"startTime":"0","endTime":"0","summary":"PolyPid (NASDAQ:PYPD) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.44) by 15.53 percent. This is a 69.67 percent increase over losses of $(1.22) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799515/polypid-q3-eps-0-37-beats-0-44-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0},{"id":"2582376820","title":"BRIEF-PolyPid Q3 Net Income USD 7.451 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376820","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376820?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:30","pubTimestamp":1762950646,"startTime":"0","endTime":"0","summary":"BRIEF-PolyPid Q3 Net Income USD 7.451 Million\n\n\nNov 12 (Reuters) - PolyPid Q3 operating income USD 7.455 million.\n\nQ3 pretax profit USD 7.429 million\nQ3 EPS USD 0.37","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXCAE96A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2582765683","title":"PolyPid Ltd - Cash Balance Expected to Fund Operations Into 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582765683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582765683?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:30","pubTimestamp":1762950601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXCAE96A:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2582490376","title":"PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582490376","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582490376?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:30","pubTimestamp":1762950600,"startTime":"0","endTime":"0","summary":"Face-to-Face Pre-NDA Meeting with the FDA Scheduled for Early December; NDA Submission for D-PLEX On Track for Early 2026 Advancements in Discussions with Potential U.S. Partners Following Positive Ph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186113/0/en/PolyPid-Provides-Corporate-Update-and-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","PYPD","BK4007","X","BK4516","BK4585","BK4588","BK4520"],"gpt_icon":0},{"id":"2582327400","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582327400?lang=en_us&edition=fundamental","pubTime":"2025-11-12 19:00","pubTimestamp":1762945200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CI&T Inc. Class A                               3Q       .10        AMC. ·Digi Intl Inc.                                  4Q       .51    4:00 PM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","IMRX","AFCG","ALUR","ARCO","TWFG","ASND","IBTA","CREX","AKRO","ABEO","AUTL","ABOS","ARX","CELC","CPRT","CINT","BABA","GUTS","AMAT","AIRG","MGX","AEMD","CABA","CRMD","CLBT","ARDT","LUNG","CAAP","AFYA","ALH","BLDP","CURI","ABSI","ATAT","ACXP","BEEM","ALVO","RSKD","ALMS","PYPD","AYTU","AEBI","ALC","ANNX","ATXS","AVBP","CRMT","CCAP"],"gpt_icon":1},{"id":"2581096786","title":"PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for \"Therapeutics Solution of the Year\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096786","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096786?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:30","pubTimestamp":1762435800,"startTime":"0","endTime":"0","summary":"'\" \"We are deeply honored by this recognition, which recognizes the importance of our mission to address one of healthcare's most persistent challenges,\" said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. \"With SSIs accounting for 20% to 31% of all hospital-acquired infections1 , D-PLEX represents a significant breakthrough. Our Phase 3 SHIELD II trial demonstrated a remarkable relative risk reduction of 58%  in SSIs following abdominal colorectal surgery, addressing a critical gap where current approaches often fall short. At a time when hospitals face complex challenges in both preventing and reporting infections, D-PLEX has the potential to transform surgical care by directly improving patient outcomes and hospital efficiency through meaningful infection reduction.\" D-PLEX has received Breakthrough Therapy Designation, three QIDP designations, and three Fast Track designations from the U.S. Food and Drug Administration. NDA submission is expected early 2026. About D-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182586/0/en/PolyPid-s-D-PLEX-Wins-BioTech-Breakthrough-Award-for-Therapeutics-Solution-of-the-Year.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","BK4520","BK4516","PYPD","BK4585","BK4139","LENZ","BK4007","BK4539","BK4588","BK4006"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":-0.0559},{"period":"1month","weight":0.1114},{"period":"3month","weight":0.3425},{"period":"6month","weight":0.2127},{"period":"1year","weight":0.3549},{"period":"ytd","weight":0.0115}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.103},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.072795},{"month":2,"riseRate":0.4,"avgChangeRate":-0.010622},{"month":3,"riseRate":0.2,"avgChangeRate":-0.088788},{"month":4,"riseRate":0.6,"avgChangeRate":-0.021004},{"month":5,"riseRate":0.4,"avgChangeRate":-0.000865},{"month":6,"riseRate":0.2,"avgChangeRate":-0.006444},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.076054},{"month":8,"riseRate":0.333333,"avgChangeRate":0.004327},{"month":9,"riseRate":0,"avgChangeRate":-0.267226},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.05946},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027739},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.103805}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction